Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01864122 · ClinicalTrials.gov registry record
Predictive Value of Coronary Heart Disease (CHD) Biomarkers for CHD Death
A clinical trial, sponsored by Tufts University.
- Completed
- Registry status
- 2,448
- Enrollment target
NCT01864122: Completed study, sponsored by Tufts University.
NCT01864122 is a clinical trial that has completed, run by Tufts University. The registered enrollment target is 2,448 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01864122 has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- 2,448 participants
- Enrollment target
Study Summary
The overall objective of this research proposal is to determine whether the predictive value of using plasma concentrations of selected nutrient biomarkers of food intake determined using a single plasma sample either alone or in combination are stronger, objective predictors of subsequent death from coronary heart disease (CHD) or myocardial infarct (MI) compared to selected food intake data derived from subjective, self-reported food frequency questionnaires.
Primary Outcome
phospholipid fatty acid profiles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,448 participants |
| Start Date | 2007-01 |
| Est. Completion | 2010-10 |
What the finished NCT01864122 record still lists
NCT01864122 is an observational study that tracks outcomes without assigning an intervention. Its 2,448 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01864122 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01864122 about?
NCT01864122 is a clinical study titled "Predictive Value of Coronary Heart Disease (CHD) Biomarkers for CHD Death". The overall objective of this research proposal is to determine whether the predictive value of using plasma concentrations of selected nutrient biomarkers of food intake determined using a single plasma sample either alone or in combination are stronger, objective predictors of subsequent death fro...
What is the current status of trial NCT01864122?
This trial is currently completed. The enrollment target is 2,448 participants. The study started on 2007-01. Estimated completion is 2010-10.
Who is sponsoring clinical trial NCT01864122?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06898593 · 2,448 participants · NA
Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
- NCT06128304 · 2,436 participants · NA
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
- NCT06676904 · 2,433 participants · NA
Neonatal Platelet Transfusion Threshold Trial
- NCT05345951 · 2,425 participants · NA
Project e-PBI+ - Parent Intervention to Reduce College Student Drinking and Cannabis Use
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia